Navigation Links
Consolidation Among Chicago Physicians Likely to Increase
Date:8/25/2009

NASHVILLE, Tenn., Aug. 25 /PRNewswire/ -- HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that while the medical community in Chicago is more consolidated than most large cities, with multiple large physician groups affiliated with health systems, the physician segment is likely to grow even more consolidated in the future. According to the recent Chicago Market Overview, with lower patient volumes, a higher percentage of uninsured patients and tighter access to capital, consolidation is likely for local physicians who have already been dealing with stagnant reimbursement from insurers and increased costs such as electronic medical records and malpractice insurance.

"While increased consolidation will provide Chicago physicians with additional resources and better leverage with insurers, it's not all positive for the medical community, particularly for those physicians who value greater independence," said Mark Cherry, analyst with HealthLeaders-InterStudy. "Such consolidation can also be a challenge for pharmaceutical sales representatives because health systems are more likely to require them to make appointments to see physicians."

Hospitals, looking for referral streams and added leverage against health plans, are eager to employ physicians. Additionally, greater consolidation gives health systems an increased ability to streamline clinical practices. One example of this consolidation trend is Chicago's Advocate Health Care's recent acquisition of Midwest Physician Group, a multispecialty practice that previously sent the majority of its patients to St. James Hospital.

"The consolidation among physician groups may be the first step in greater consolidation across the Chicago market, as the healthcare sector will be more aligned with two main segments: health systems and health plans," said Cherry. "Look for tensions between these two segments to increase."

Why Pharmaceutical Companies Need Market Overviews

Market Overviews provide a detailed analysis of local healthcare market drivers in 87 of the nation's most dynamic metro areas, allowing pharmaceutical executives to quickly gain local area expertise. Each report provides local-level insights into: health systems and hospitals, physicians, health plans, Medicare/Medicaid, pharmaceutical environment, legislation and employers.

About HealthLeaders-InterStudy

HealthLeaders-InterStudy, a Decision Resources, Inc. company, is the authoritative source for managed care data, analysis and news. For more information, please visit www.HL-ISY.com.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Lisa Osgood                               Elizabeth Marshall
    HealthLeaders-InterStudy                  Decision Resources, Inc.
    781-296-2606                              781-296-2563
    losgood@hl-isy.com                        emarshall@dresources.com


'/>"/>
SOURCE HealthLeaders-InterStudy
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cardinal Health Formalizes Consolidation of Businesses Into Two Primary Operating and Reporting Segments
2. Insurance Department to Hold Statewide Meetings on Proposed Consolidation of Independence Blue Cross, Highmark
3. Insurance Department Will Hold Public Hearings on Proposed Consolidation of Highmark, Independence Blue Cross
4. Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008
5. Akela Pharma Inc. Completes Share Consolidation
6. Blood Mercury Levels Rising Among U.S. Women
7. Better Pap Smear Follow-Up Needed Among Lower-Income Women
8. Confronting Health Disparities Among Lesbian, Gay, Bisexual and Transgender Youth
9. Cancer Deaths Declining, Especially Among Young
10. Carefxs New Referral Management Solution Increases Hospital Referral Volume, Enhances Collaboration Among Specialists, PCPs and Patients
11. Sharing Prescription Meds Common Among U.S. Teens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... 05, 2016 , ... BSI and Brenntag Canada have been appointed by Chr. ... of their natural fruits and beverage colorants effective November 1, 2016. ... our Life Sciences product portfolio,” said Steve Brauer, President of Brenntag Specialties, Inc. “Representing ...
(Date:12/5/2016)... , ... December 05, 2016 ... ... Great Point Partners ("GPP") portfolio company, today announced it has acquired the ... TCS was previously a subsidiary of Chiltern International and focuses on ...
(Date:12/5/2016)... ... ... The new knee compression sleeves come as a pair which will provide ... lifting and any sport that requires knee compression or protection from the demands ... higher quality knee sleeve performance. Firstly it is made out of premium 7mm thick ...
(Date:12/5/2016)... OH (PRWEB) , ... December 05, 2016 , ... ... engineering solution called the CardioQuick Patch® significantly improves the reproducibility and accuracy of ... in various healthcare settings. , Over the last 60 years, studies have ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... "Best Surgical Body Shaping" at the 2016 Anti-Aging & Beauty Awards ... , The Aesthetic & Anti-Aging Medicine European Congress (AMEC) brings together ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... TAIPEI, Taiwan , Dec. 5, 2016 ... alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete Hematologic Response ... and tolerability profile of ropeginterferon alfa-2b versus HU ... ongoing long-term follow-up trial CONTINUATION-PV to obtain European marketing authorization ... present this data to the FDA as it seeks approval ...
(Date:12/4/2016)... SAN DIEGO , Dec. 3, 2016 Johnson ... filed on behalf of purchasers of Zimmer Biomet Holdings, Inc. ... September 7, 2016 through October 31, 2016 (the "Class Period"). ... It designs, manufactures, and markets orthopaedic reconstructive products, such as ... ...
(Date:12/4/2016)... 3, 2016   Pairnomix, LLC, a genetic research ... recognized by the White House, today announced that findings from ... identification of candidate therapies for a patient with epileptic encephalopathy ... were presented at the 70 th Annual Meeting of ... TX , December 2-6, 2016.  Pairnomix, unique ...
Breaking Medicine Technology: